Klivira
Request demo

Optimizing Infectious Disease Claim Status Tracking with Automation

For infectious disease practices, efficient infectious disease claim status tracking is critical to maintaining revenue velocity, especially with high-cost antivirals, antifungals, and complex OPAT regimens.

The financial integrity of infectious disease practices hinges on timely reimbursement for high-value treatments. Manual claim status tracking for these complex therapies often leads to administrative overhead, delayed payments, and lost revenue. Klivira automates this critical workflow, providing clarity and control over your revenue cycle.

The Unique Challenges of Infectious Disease Claim Status Tracking

Infectious disease (ID) practices frequently manage prior authorizations for high-cost therapies such as antivirals (HCV, HIV), antifungals, and Outpatient Parenteral Antibiotic Therapy (OPAT). These treatments, often long-term and involving complex drug regimens, generate a high volume of claims that demand diligent status tracking. Without automation, the sheer volume and complexity can overwhelm staff, leading to claims languishing in 'pending' status.

Manual Claim Status Workflows in ID: A Drain on Resources

Traditional claim status workflows for infectious disease treatments involve significant manual effort. Staff must periodically poll payer portals or engage in time-consuming phone calls to check the status of submitted claims. When X12 277 status responses are received, they often require manual interpretation of payer-specific codes. This manual polling overhead, coupled with status interpretation variability, frequently results in 'stuck claims' that can easily pass timely-filing windows, directly impacting the practice's revenue for essential ID services.

Klivira's Automated Approach to Infectious Disease Claim Status

Klivira's platform automates infectious disease claim status tracking by implementing scheduled X12 277 polling and ingesting X12 835 remittance advice. For payers leveraging modern data exchange, Klivira integrates FHIR ClaimResponse resources via the Da Vinci PAS umbrella. This comprehensive approach ensures that the status of claims for high-cost antivirals, antifungals, and OPAT is continuously monitored, reducing manual intervention and providing real-time visibility into the revenue cycle.

Ensuring Revenue Integrity for ID Therapies with Automated Tracking

Automated claim status tracking significantly enhances revenue integrity for infectious disease practices. Klivira normalizes payer-specific status codes into a uniform claim-state model, eliminating interpretation variability. Crucially, the platform maintains the linkage between the initial prior authorization and the eventual claim, surfacing discrepancies that could delay payment for critical ID therapies. Claims pending beyond configurable thresholds trigger automated follow-up workflows, preventing costly write-offs due to missed timely-filing deadlines.

Standards-Based Connectivity for ID Claim Workflows

Klivira leverages industry-standard protocols to ensure robust and reliable claim status communication. This includes automated handling of X12 277 for claim status inquiries and X12 835 for remittance advice. For advanced integrations, Klivira supports FHIR ClaimResponse, aligning with modern healthcare data exchange initiatives. This commitment to standards ensures seamless connectivity with diverse payers, providing accurate and timely status updates for all infectious disease claims.

Frequently asked questions

How does Klivira handle claim status for high-cost infectious disease drugs?

Klivira automates claim status tracking for all submitted claims, including those for high-cost antivirals, antifungals, and HIV regimens. Our system performs automated X12 277 polling and ingests X12 835 remittances, providing continuous, real-time updates on claim status. This proactive monitoring helps prevent delays and identifies potential issues before they impact reimbursement.

Can Klivira track claims linked to specific prior authorizations for ID therapies?

Yes, Klivira maintains a direct linkage between the prior authorization (PA) and the corresponding claim for infectious disease therapies. This feature is critical for high-cost drugs where PA is mandatory. It allows our platform to identify any discrepancies between the authorized service and the submitted claim, ensuring compliance and expediting payment.

What happens if an infectious disease claim gets 'stuck' in pending status?

Klivira's system is designed to proactively manage 'stuck claims.' If an infectious disease claim remains in 'pending' or 'review' status beyond configurable thresholds, our platform automatically triggers follow-up workflows. This can include escalating the claim for review, initiating payer outreach, or alerting your team for internal review, preventing claims from lapsing past timely-filing windows.

Does Klivira integrate with our EMR for infectious disease claim status information?

Klivira integrates with leading EMR systems, allowing for a unified view of patient, authorization, and claim data. This integration streamlines the flow of information, ensuring that claim status updates are accessible within your existing clinical and administrative workflows, directly benefiting infectious disease practices by reducing data silos and improving operational efficiency.

How does Klivira address the variability in payer-specific claim status codes?

Klivira addresses payer-specific status code variability by normalizing all X12 277 and FHIR ClaimResponse status codes into a uniform claim-state model. This standardized taxonomy eliminates manual interpretation errors and provides a consistent, clear understanding of claim status across all payers, streamlining the process for your infectious disease billing team.

Related coverage

Other infectious-disease prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo